See the following AlzForum article, including comments at the bottom from independent researchers.
Finally: Big Win on All Outcomes for Lecanemab in Phase 3 Topline Results:
See the following AlzForum article, including comments at the bottom from independent researchers.
Finally: Big Win on All Outcomes for Lecanemab in Phase 3 Topline Results:
Yes, the big question for us is does this mean the amyloid theory bears weight? (So would removing the Alpha synuclein for PD have therpudic benefits also). Maybe there's hope!